![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: VWA3A |
Gene summary for VWA3A |
![]() |
Gene information | Species | Human | Gene symbol | VWA3A | Gene ID | 146177 |
Gene name | von Willebrand factor A domain containing 3A | |
Gene Alias | VWA3A | |
Cytomap | 16p12.2 | |
Gene Type | protein-coding | GO ID | GO:0005575 | UniProtAcc | A6NCI4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
146177 | VWA3A | RNA-P6T1-P6T1-1 | Human | Lung | MIAC | 3.00e-03 | 5.87e-01 | -0.0238 |
146177 | VWA3A | RNA-P6T1-P6T1-4 | Human | Lung | MIAC | 5.54e-03 | 5.01e-01 | -0.0263 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Lung | ![]() | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ | ||
IAC: Invasive lung adenocarcinoma | ||
MIA: Minimally invasive adenocarcinoma |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
VWA3A | SNV | Missense_Mutation | novel | c.3263N>A | p.Ser1088Tyr | p.S1088Y | A6NCI4 | protein_coding | deleterious(0) | probably_damaging(0.975) | TCGA-EP-A3JL-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
VWA3A | SNV | Missense_Mutation | rs774229691 | c.2045G>A | p.Arg682His | p.R682H | A6NCI4 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-44-5644-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
VWA3A | SNV | Missense_Mutation | c.3284C>A | p.Ala1095Glu | p.A1095E | A6NCI4 | protein_coding | tolerated(0.44) | benign(0.019) | TCGA-44-7659-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
VWA3A | SNV | Missense_Mutation | c.2641T>A | p.Cys881Ser | p.C881S | A6NCI4 | protein_coding | tolerated(0.13) | benign(0.048) | TCGA-50-5045-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |
VWA3A | SNV | Missense_Mutation | c.2452N>T | p.Thr818Ser | p.T818S | A6NCI4 | protein_coding | tolerated(0.4) | benign(0.022) | TCGA-55-8207-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
VWA3A | SNV | Missense_Mutation | c.1451G>A | p.Arg484Lys | p.R484K | A6NCI4 | protein_coding | tolerated(0.7) | benign(0.003) | TCGA-55-A48Y-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Chemotherapy | carboplatin | CR | |
VWA3A | SNV | Missense_Mutation | c.1800N>G | p.Asp600Glu | p.D600E | A6NCI4 | protein_coding | tolerated(0.1) | possibly_damaging(0.615) | TCGA-64-1679-01 | Lung | lung adenocarcinoma | Female | <65 | III/IV | Chemotherapy | cisplatin | SD | |
VWA3A | SNV | Missense_Mutation | novel | c.2263A>T | p.Arg755Trp | p.R755W | A6NCI4 | protein_coding | deleterious(0) | possibly_damaging(0.844) | TCGA-69-A59K-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | cisplatin | SD |
VWA3A | SNV | Missense_Mutation | c.3308T>A | p.Leu1103Gln | p.L1103Q | A6NCI4 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-75-6214-01 | Lung | lung adenocarcinoma | Female | Unknown | III/IV | Unknown | Unknown | PD | |
VWA3A | SNV | Missense_Mutation | c.3071T>C | p.Met1024Thr | p.M1024T | A6NCI4 | protein_coding | tolerated(0.1) | benign(0.007) | TCGA-78-7158-01 | Lung | lung adenocarcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |